NY State-Approved Tests

EGL Genetics received a NY State Permit. The tests listed below do not require a Restricted Permit for Non-Permitted Testing. Please note that any tests not listed below now require a Restricted Permit for Non-Permitted Testing before testing can proceed. NY State Restricted Permit for Non-Permitted Testing Instructions can be downloaded here. If you have any questions, please contact the lab at 404-778-8499.

All testing originating from NY State requires a consent form(s). For NY State-approved tests, consent forms are available via the table below. For consent forms for all other testing, please click here.

Test Code Test Name Consent Form(s) Required
MM470 Pan-Ethnic Carrier Screen: Gene Sequencing Panel Informed Consent for NY Clients – Fragile-X Syndrome
Informed Consent for NY Clients – Pan-Ethnic/Ashkenazi Jewish Carrier Screen
MM480 Pan-Ethnic Carrier Screen: Targeted Mutation Panel Informed Consent for NY Clients – Fragile-X Syndrome
Informed Consent for NY Clients – Pan-Ethnic/Ashkenazi Jewish Carrier Screen
MM490 Spinal Muscular Atrophy: Carrier Screen Informed Consent for NY Clients – Pan-Ethnic/Ashkenazi Jewish Carrier Screen
MM500 Ashkenazi Jewish Carrier Screen: Gene Sequencing Panel Informed Consent for NY Clients – Fragile-X Syndrome
Informed Consent for NY Clients – Pan-Ethnic/Ashkenazi Jewish Carrier Screen
MM510 Ashkenazi Jewish Carrier Screen: Targeted Mutation Analysis Informed Consent for NY Clients – Fragile-X Syndrome
Informed Consent for NY Clients – Pan-Ethnic/Ashkenazi Jewish Carrier Screen
MM570 ACOG/ACMG Carrier Screen: Gene Sequencing Panel Informed Consent for NY Clients – Pan-Ethnic/Ashkenazi Jewish Carrier Screen
MM580 ACOG/ACMG Carrier Screen: Targeted Mutation Panel Informed Consent for NY Clients – Pan-Ethnic/Ashkenazi Jewish Carrier Screen
MFRAX Fragile X: CGG Repeat Analysis Informed Consent for NY Clients – Fragile-X Syndrome
FJ Fragile X-associated Tremor/Ataxia Syndrome (FXTAS): CGG Repeat Analysis Informed Consent for NY Clients – Fragile-X Syndrome
YD Y-Chromosome: Microdeletion Analysis Informed Consent for NY Clients – Chromosome Y Microdeletion
CB Chromosome Analysis: Peripheral Blood (Age: Less than 6mo) Informed Consent for NY Clients – Chromosome Analysis
CA Chromosome Analysis: Peripheral Blood (Age: 6 months and above) Informed Consent for NY Clients – Chromosome Analysis
CV Chromosome Analysis: Chorionic Villi Informed Consent for NY Clients – Chromosome Analysis
AD Chromosome Analysis: Amniotic Fluid Informed Consent for NY Clients – Chromosome Analysis
CO Chromosome Analysis: Products of Conception (POC) Informed Consent for NY Clients – Chromosome Analysis
VA Chromosomal Microarray: EmArray Cyto Informed Consent for NY Clients – Postnatal Microarray
CMSNP Chromosomal Microarray: CytoScan SNP Array Informed Consent for NY Clients – Postnatal Microarray
CMPOC Chromosomal Microarray: CytoScan SNP Array POC Informed Consent for NY Clients – Products of Conception Microarray Analysis
CMPRS Chromosomal Microarray: CytoScan SNP Array Prenatal Informed Consent for NY Clients – Prenatal Microarray
CMPRE Chromosomal Microarray: EmArray Cyto Prenatal Informed Consent for NY Clients – Prenatal Microarray
EG Duchenne/Becker Muscular Dystrophy: DMD Gene Deletion/Duplication Informed Consent for NY Clients – DMD Gene Deletion/Duplication

In The Spotlight

Christin Collins

Dr. Collins is a board-certified molecular geneticist and a laboratory director for the Molecular Genetics Laboratory.

New and Updated Gene Panels

Industry-leading number of gene panels

EGL Next Generation Sequencing Panels include comprehensive, evidence-based gene lists, improved turnaround times, and reduced pricing.